Chemours Co: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Nov 5, 2015 and accepted by EDGAR at Nov 5, 2015, 17:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-07-01 to 2015-09-30 | $1.49bn | us-gaap:Revenues |
| Revenue | 9 months2015-01-01 to 2015-09-30 | $4.36bn | us-gaap:Revenues |
| Cost of revenue | 3 months2015-07-01 to 2015-09-30 | $1.22bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2015-01-01 to 2015-09-30 | $3.62bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2015-07-01 to 2015-09-30 | $264.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2015-01-01 to 2015-09-30 | $742.0m | us-gaap:GrossProfit |
| Research and development | 3 months2015-07-01 to 2015-09-30 | $18.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2015-01-01 to 2015-09-30 | $68.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2015-07-01 to 2015-09-30 | $157.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2015-01-01 to 2015-09-30 | $481.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2015-07-01 to 2015-09-30 | $51.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2015-01-01 to 2015-09-30 | $79.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-07-01 to 2015-09-30 | −$78.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-01-01 to 2015-09-30 | −$63.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-07-01 to 2015-09-30 | −$29.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2015-01-01 to 2015-09-30 | −$4.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-07-01 to 2015-09-30 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2015-01-01 to 2015-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-07-01 to 2015-09-30 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2015-01-01 to 2015-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-07-01 to 2015-09-30 | 180,968,049 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-01-01 to 2015-09-30 | 180,968,049 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-01-01 to 2015-09-30 | −$120.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2015-01-01 to 2015-09-30 | $392.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2015-01-01 to 2015-09-30 | $100.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2015-09-30 | $215.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $2.48bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $6.45bn | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $1.50bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-30 | $6.36bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-09-30 | $3.92bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-09-30 | $38.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-09-30 | $86.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001627223-15-000050. Last ingested by Listed: Nov 5, 2026, 19:57 ET. Listed shows no prices and gives no investment advice.